Intensive Chemo-immunotherapy as First Line Treatment in Adult Patients With Peripheral T- Cell Lymphoma

NCT01679860 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

92

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma, T-Cell, Peripheral

Interventions

PROCEDURE: Clin A. CHOP-CAMPATH (Chemo-immunotherapy) + SCT
DRUG: Clin B (CHOP- CAMPATH) Chemo-immunotherapy

Sponsor

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano